European shares ended lower on Wednesday, following a broad rally earlier in the session, hurt by a drop in utilities shares ...

We recently compiled a list of the 8 Best European Stocks To Buy According to Hedge Funds. In this article, we are going to ...

The former U.S. President had vowed to impose a 10% tariff on imports from all countries if he won, and said the European ...

ESSENCE is a double-blinded, 240-week study that involves 1,200 adults with MASH and stage two or three liver fibrosis.

EUROPEAN shares ended lower on Wednesday, following a broad rally earlier in the session, hurt by a drop in utilities shares on fears that US President-elect Donald Trump could halt fresh approvals ...

European Union antitrust regulators will decide by Dec. 6 whether ... underscores Novo Nordisk’s push to boost output of its ...

Wegovy revenue climbed to 17.3 billion Danish kroner ($2. ... Apple is set to be fined by the European Union's antitrust ...

In the ESSENCE trial, semaglutide improved liver fibrosis in patients with metabolic dysfunction-associated steatohepatitis ...

AstraZeneca said on Monday its experimental weight-loss pill, licensed from China's Eccogene, was safe and tolerable in an ...

Novo Nordisk’s Wegovy helped heart disease patients end up in the hospital ... called Phase 2b trial with its obesity ...

Novo Nordisk's (NVO) third-quarter earnings were solid enough to soothe investor jitters and turn the market's attention toward upcoming trial results for a potentially game-changing new weight-loss ...

Service Employees International Union (SEIU) and others expressed concerns in a letter to the FTC about the $16.5 billion deal, which Novo Holdings has said would boost supply of Wegovy ...